Investor Relations

AMS at a Glance

Advanced Medical Solutions Group plc is a leading developer and manufacturer of innovative and technologically advanced products for the global surgical, woundcare and wound closure markets. Our strategy is based around:

  • Growth - Expanding our global presence
  • Innovation - Designing and developing leading products
  • Value - Offering cost-effective product solutions

Financial Calendar

Full Year End

31 December 2016

Half Year Results

14 September 2016

Trading Update

5 July 2016

Half Year End

30 June 2016

Final Dividend Payment

10 June 2016


2 June 2016

Annual Report & Notice of AGM

3 May 2016
View Full Calendar

Financial Reports

2015 Annual Report

April 2016

Interim Report - 2015

October 2015

2014 Annual Report

April 2015

2014 Interim Report

September 2014

2013 Annual Report

April 2014

2013 Interim Report

September 2013
View All Reports


Winner- Partnership with the NHS
AMS wins Medilink North West Partnership with the NHS award 2016

Advanced Medical Solutions Group plc is pleased to announce they have been awarded the Partnership with the NHS award at the Medilink North West... Read More

View More News

Latest Financial Highlights


Group revenue increased by 9% to £68.6 million (2014: £63.0 million), representing growth of 11% on a constant currency basis and an increase in adjusted profit before tax of 12% to £17.4 million (2014: £15.6 million).

The strong cash flow generation of the Group was again evident and we ended the year with net cash of £34.2 million (2014: £17.3 million). We continue to be in robust financial health and are well positioned to invest in internal and external opportunities in line with the Group’s strategy.

The performance of LiquiBand® in the US was particularly strong. We continue to gain market share and are fast approaching our initial goal of building a 20% market share with our LiquiBand® range in the US. We are also pleased with the success of our LiquiBand® Fix8™ hernia mesh fixation device, our first device using medical adhesive inside the body. It is now being sold in 20 countries and has achieved £1 million of sales in its first full year since launch.

We have also received a number of product and market approvals in the year, demonstrating our continued success in innovation, with launches planned in 2016, supporting the sales growth in the Group.